Henry Schein (HSIC) to Release Quarterly Earnings on Tuesday

Henry Schein (NASDAQ:HSIC) is scheduled to announce its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.99 per share for the quarter. Henry Schein has set its FY 2024 guidance at 5.000-5.160 EPS and its FY24 guidance at $5.00 to $5.16 EPS.Parties that wish to register for the company’s conference call can do so using this link.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business had revenue of $3.02 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period in the previous year, the company earned $1.21 earnings per share. Henry Schein’s quarterly revenue was down 10.5% on a year-over-year basis. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Henry Schein Stock Performance

Shares of HSIC stock opened at $67.78 on Monday. Henry Schein has a 52 week low of $60.01 and a 52 week high of $82.63. The firm has a 50 day moving average of $73.46 and a two-hundred day moving average of $72.32. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $8.71 billion, a PE ratio of 21.52, a P/E/G ratio of 1.68 and a beta of 0.87.

Analysts Set New Price Targets

Several research analysts recently commented on the company. JPMorgan Chase & Co. boosted their target price on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. SVB Leerink began coverage on shares of Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 target price on the stock. Piper Sandler lifted their price target on shares of Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Finally, Jefferies Financial Group lifted their price objective on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $81.09.

Insider Buying and Selling at Henry Schein

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the sale, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.